Crispr Therapeutics shares owned by Mason & Associates
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Mason & Associates
from 13F filings
Historical chart of Mason & Associates investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Mason & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Mason & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $382k | 5.9k | 64.81 |
| 2025-06-30 | $287k | 5.9k | 48.64 |
| 2025-03-31 | $201k | 5.9k | 34.03 |